Paul Weiss Reps Universal In $1.25B CVS Deal
Shareholders of Universal American, a leading Medicare prescription drug plan sponsor, are expected to receive about $12.80 to $13 per share as part of the deal, Universal American said in a statement Friday.
The transaction, subject to the approval of Universal American shareholders and regulators, is expected to close by the...
Already a subscriber? Click here to login